Research Fund Is Caught In AZT Debate

Amid controversy surrounding its sole supporter and namesake, pharmaceutical supplier Burroughs Wellcome Co., the Burroughs Wellcome Fund strives to fulfill the policy set by its founders 34 years ago. Under a logo depicting the watchful eye of Horus, the Egyptian god of medicine, the fund supports research and educational efforts in medical science. In its first fiscal year, 1955-56, the fund gave out $5,800. Since then, the grant amounts approved each year have grown significantly. In the

Written byAngela Martello
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Amid controversy surrounding its sole supporter and namesake, pharmaceutical supplier Burroughs Wellcome Co., the Burroughs Wellcome Fund strives to fulfill the policy set by its founders 34 years ago. Under a logo depicting the watchful eye of Horus, the Egyptian god of medicine, the fund supports research and educational efforts in medical science.

In its first fiscal year, 1955-56, the fund gave out $5,800. Since then, the grant amounts approved each year have grown significantly. In the past fiscal year, 1988-89, the fund approved awards totaling more than $5.7 million, almost a 1,000-fold increase over the initial endowment. The capability to give reflects its benefactor’s ability to get, since the foundation’s coffers are stocked entirely out of the drug company’s profits (see accompanying graph). Last year, the company donated $5 million to the fund, as opposed to the $160,000 it donated back in 1955-56.

But it is the Research Triangle ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies